Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Alnylam and Inceptive have reached a strategic AI collaboration to accelerate the development of RNAi therapy On June 3, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) and lnceptive Nucleics, a company dedicated to building life science foundation models, announced today that they have signed a strategic partnership agreement aimed at accelerating the development of innovative therapeutic drugs
R., Juhl, C
WeightWatchers Launches New Behavior Change Program Designed to Support the Unique Needs of Individuals on GLP-1 Medications First-ever nutrition and activity program to complement a GLP-1 weight loss journey for those who receive medication through the new WeightWatchers Clinic or their medical provider NEW YORK, Dec
Anxiety, however, was slower to decrease, and opioid withdrawal required more DSIP injections over a longer period of time
Clinical trials revealed significant weight loss with liraglutide at doses of up to 3.0 mg per day, with participants losing an average of 46 kg over 20 weeks, outperforming placebo and orlistat (38)
